|
|
|
|
LEADER |
00000cas a22000002a 4500 |
001 |
ocm04943212 |
003 |
OCoLC |
005 |
20141204200727.0 |
008 |
081106c19949999gb ar r 0 0eng d |
010 |
|
|
|a 95182879
|
035 |
|
|
|a (Sirsi) a445542
|
040 |
|
|
|a DLC
|d UV#
|
043 |
|
|
|a eng
|
050 |
|
4 |
|a RB145
|b H45
|
245 |
0 |
0 |
|a Hematology/oncology clinics of north america.
|
250 |
|
|
|a Ed.B.Saunders Company.
|
246 |
1 |
|
|i Ediciones 1994-
|
260 |
|
|
|a Londres, :
|b Ed. B. SAunders Company,
|c 1991-
|
300 |
|
|
|a v. ;
|b il. ;
|c 23 cm.
|
310 |
|
|
|a Bimestral.-
|
505 |
|
|
|t v. 1994.New directions in breast cancer(v.1),New drug therapy(v.2),Tumor Makers in adult solid maligmancies(V.3)Diagnostic hematology(v.4),Erythopoietin: Basic and clinical aspects(5),Transfusion medicine I(v.6)--
|t v. 1995. Transfusion medicine II(v.1)Drug resistance in clinical oncology and hematology(v.2),Sarcomas I(v.3),Sarcomas II(v.4)Cutaneous T-Cell Lymphoma( v.5),Wils tumor(v.6).
|
650 |
|
4 |
|a Hematología.
|
650 |
|
4 |
|a Oncología.
|
901 |
|
|
|a Z0
|b UV#
|
902 |
|
|
|a DGBUV
|
596 |
|
|
|a 35
|
942 |
|
|
|c LIBRO
|
999 |
|
|
|c 220202
|d 220202
|